Correction: AAA237, an SKP2 inhibitor, suppresses glioblastoma by inducing BNIP3-dependent autophagy through the mTOR pathway

Yizhi Zhang; Wan Li; Yihui Yang; Sen Zhang; Hong Yang; Yue Hao; Xu Fang; Guanhua Du; Jianyou Shi; Lianqiu Wu; Jinhua Wang

doi:10.1186/s12935-024-03473-4

Correction: AAA237, an SKP2 inhibitor, suppresses glioblastoma by inducing BNIP3-dependent autophagy through the mTOR pathway

Cancer Cell Int. 2024 Aug 17;24(1):293. doi: 10.1186/s12935-024-03473-4.

Authors

Yizhi Zhang^{1

2}, Wan Li^{1

2}, Yihui Yang^{1

2}, Sen Zhang^{1

2}, Hong Yang^{1

2}, Yue Hao^{1

2}, Xu Fang^{1

2}, Guanhua Du^{1

2}, Jianyou Shi³, Lianqiu Wu⁴, Jinhua Wang^{5

6}

Affiliations

¹ The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, 100050, China.
² Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China.
³ Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610072, Sichuan, China. [email protected].
⁴ Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China. [email protected].
⁵ The State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing, 100050, China. [email protected].
⁶ Key Laboratory of Drug Target Research and Drug Screen, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100050, China. [email protected].

No abstract available

Publication types

Published Erratum